Tag: AstraZeneca
17 Results
-
Antibody drug Evusheld can fight Omicron variant: AstraZeneca
AstraZeneca, a British-Swedish pharmaceutical company, has reported that its antibody medication 'Evusheld' is effective against Covid-19's novel vaccine-evading Omicron strain.
December 24, 2021 -
AstraZeneca to use new vax technology to treat cancer, heart disease
Imperial scientists had aimed to use the technology to design a Covid-19 jab. However, it never progressed further than stage two clinical testing.
September 28, 2021 -
AstraZeneca does not raise high blood clot risk post 2nd dose: Study
"No specific risk factors or definitive cause for TTS following Covid-19 vaccination have been identified and AstraZeneca continues to perform and support ongoing investigations of potential mechanisms," the study noted.
July 29, 2021 -
AstraZeneca Covid vaccine protection may last a lifetime: Study
Previous studies have shown that the Oxford jab is more effective in generating T-cells than mRNA vaccines like Pfizer and Moderna.
July 16, 2021 -
Thailand to limit locally-manufactured AstraZeneca exports
The authority will negotiate with Siam Bioscience Co. and recommend that the manufacturer supply the vaccine to Thailand
July 15, 2021 -
Canada to donate 17.7mn AstraZeneca vax to other countries
The AstraZeneca doses are coming from the advance purchase agreement the government struck with the company and that these doses, which will be manufactured in the United States
July 13, 2021 -
AstraZeneca tests Covid booster shots against Beta-variant
The study aims to enroll 2,250 participants from the UK, South Africa, Brazil, and Poland to build immunity against the Beta Covid variant
June 28, 2021 -
Deliver 50mn vax doses or face fines: Court orders AstraZeneca
European Commission President Ursula von der Leyen welcomed the decision, saying that the EU's vaccination programme was built on a sound legal basis
June 19, 2021 -
Pfizer, AstraZeneca Covid jabs highly effective against Delta variant
The analysis suggests that the Pfizer-BioNTech vaccine is 96 per cent effective against hospitalisation after two doses, while the Oxford-AstraZeneca vaccine is 92 per cent effective against hospitalisation after two doses.
June 15, 2021 -
AstraZeneca jab can be administered to all age-groups: EMA
The clarification came after Marco Cavaleri, head of the EMA's vaccine strategy, was quoted as saying by an Italian newspaper that the vaccine shots should not be administered to people aged over 60 and younger age groups amid fears over very rare blood clotting.
June 15, 2021 -
A new normal?
While Covishield and Covaxin may not be accepted in many countries, should they not pass muster within India? Yet even fully vaccinated and healthy citizens need a negative RT-PCR report to travel to several states including West Bengal and Punjab.
May 26, 2021 -
Antibody reaction traced to blood clots linked to AstraZeneca jabs
The reports which looked into the issue of blood clots linked to AstraZeneca jabs were published in The New England Journal of Medicine.
April 12, 2021 -
Surplus AstraZeneca vaccines in rich nations must go to poor countries, says WHO
WHO Director-General Tedros Adhanom Ghebreyesus said high income countries had on average vaccinated one in four people while in low income countries it was one in more than 500.
April 11, 2021 -
Trials for Astrazeneca’s UK vaccine on kids halted amidst reports linking it to blood clots
The trial, which started in February, is evaluating whether the vaccine generates a strong immune response in those aged between 6 and 17
April 7, 2021 -
Link between AstraZeneca vaccine and blood clots clear: European Medical Association official
There is a causal link between the coronavirus vaccine developed by AstraZeneca and very rare cases of blood clots, although it remains unclear what the connection is and the possible causes are likewise still unknown, a senior European Medicines Agency (EMA) expert told an Italian media on Tuesday. “It is clear that an association exists” …
April 7, 2021 -
7 blood clot deaths in UK after AstraZeneca jab
After more than 18 million people have received vaccinations with AstraZeneca`s jab in the UK, the country`s health regulator said seven people had died due to rare blood clots, although the cause remains unclear. “The benefits in preventing a Covid-19 infection and its complications continue to outweigh any risks and the public should continue to …
Continue reading "7 blood clot deaths in UK after AstraZeneca jab"
April 3, 2021 -
COVID-19: UK uncovers 25 new rare blood clot cases linked to AstraZeneca Vaccine
A UK-based agency stated that it has found 25 more cases of rare blood clot events in people that have taken the AstraZeneca COVID-19 vaccine. On March 18, the Medicines and Healthcare products Regulatory Agency had reported five cases of a rare brain blood clot among 11 million administered shots. On Thursday the medical agency …
Continue reading "COVID-19: UK uncovers 25 new rare blood clot cases linked to AstraZeneca Vaccine"
April 2, 2021